Louis Moore Bacon's MDGL Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 5,561 shares of Madrigal Pharmaceuticals, Inc. (MDGL) worth $2.8 M, representing 0.05% of the portfolio. First purchased in 2026-Q3, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Louis Moore Bacon has initiated a new position in MDGL, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's Madrigal Pharmaceuticals (MDGL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Madrigal Pharmaceuticals (MDGL) Trades by Louis Moore Bacon
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | +5,561 | New Buy | 5,561 | $503.96 |
Louis Moore Bacon's Madrigal Pharmaceuticals Investment FAQs
Louis Moore Bacon first purchased Madrigal Pharmaceuticals, Inc. (MDGL) in Q3 2026, acquiring 5,561 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held Madrigal Pharmaceuticals, Inc. (MDGL) for 1 quarters since Q3 2026.
Louis Moore Bacon's largest addition to Madrigal Pharmaceuticals, Inc. (MDGL) was in Q3 2026, adding 5,561 shares worth $2.8 M.
According to the latest 13F filing for Q3 2026, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 5,561 shares of Madrigal Pharmaceuticals, Inc. (MDGL), valued at approximately $2.8 M.
As of the Q3 2026 filing, Madrigal Pharmaceuticals, Inc. (MDGL) represents approximately 0.05% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings.
Louis Moore Bacon's peak holding in Madrigal Pharmaceuticals, Inc. (MDGL) was 5,561 shares, as reported at the end of Q3 2026.